Geneos Wealth Management’s Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust GBAB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q3
Sell
-1,857
Closed -$33K 2232
2022
Q2
$33K Buy
1,857
+22
+1% +$408 ﹤0.01% 1462
2022
Q1
$36K Buy
1,835
+19
+1% +$395 ﹤0.01% 1517
2021
Q4
$43K Buy
1,816
+17
+0.9% +$402 ﹤0.01% 1545
2021
Q3
$43K Buy
1,799
+11
+0.6% +$272 ﹤0.01% 1560
2021
Q2
$43K Sell
1,788
-1,003
-36% -$24.1K ﹤0.01% 1551
2021
Q1
$66K Buy
2,791
+6
+0.2% +$146 ﹤0.01% 1484
2020
Q4
$64K Buy
2,785
+2,185
+364% +$54.1K ﹤0.01% 1336
2020
Q3
$14K Hold
600
﹤0.01% 1825
2020
Q2
$13K Hold
600
﹤0.01% 1803
2020
Q1
$12K Buy
+600
New +$14K ﹤0.01% 1724
2016
Q3
Sell
-225
Closed -$5K 1975
2016
Q2
$5K Hold
225
﹤0.01% 1513
2016
Q1
$5K Buy
+225
New +$5.04K ﹤0.01% 1479

Other funds holding GBAB

Geneos Wealth Management's GBAB Position: Q3 2022 in Review

Geneos Wealth Management sold out of Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust (GBAB) in Q3 2022, closing a stake of 1,857 shares — an estimated $33K sold.

Geneos Wealth Management first reported a position in GBAB in Q1 2016 and held it in 12 quarters. The position peaked at $66K in Q1 2021. 57 funds tracked by Wall St. Rank hold GBAB as of Q3 2022.

  • Geneos Wealth Management reported no remaining Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust position as of Q3 2022 after selling out during the quarter.
  • Geneos Wealth Management sold 1,857 Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust shares in Q3 2022, an estimated $33K.
  • Geneos Wealth Management first reported a position in Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust in Q1 2016 and held it in 12 quarters.
  • Geneos Wealth Management's Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust position peaked at $66K in Q1 2021.
  • 57 funds tracked by Wall St. Rank held Guggenheim Taxable Municipal Bond & Investment Grade Debt Trust as of Q3 2022.

Based on Geneos Wealth Management's 13F filing for Q3 2022, filed 14 Nov 2022.